Pecs II Block Versus Surgeon Infiltration for Open Subpectoral Biceps Tenodesis
Status:
Recruiting
Trial end date:
2023-08-07
Target enrollment:
Participant gender:
Summary
A phase IV, randomized, single-blind, single-center study measuring the effects of Pecs II
block with 0.25% bupivacaine versus surgeon infiltration with 0.25% bupivacaine on
postoperative pain control and opioid utilization in participants who undergo open
subpectoral tenodesis.